AIM
AYLA

ARK Investment Management’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

ARK Investment Management’s Portfolio AYLA Stock Details AYLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-113,450
Closed -$1.25M – 295
2020
Q4 		$1.25M Buy
113,450
+101,387
+840% +$1.17M ﹤0.01% 206
2020
Q3 		$139K Buy
+12,063
New +$141K ﹤0.01% 201

Other funds holding AYLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

ARK Investment Management's AYLA Position: Q1 2021 in Review

ARK Investment Management sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q1 2021, closing a stake of 113,450 shares — an estimated $1.25M sold.

ARK Investment Management first reported a position in AYLA in Q3 2020 and held it in 2 quarters. The position peaked at $1.25M in Q4 2020. 11 funds tracked by Wall St. Rank hold AYLA as of Q1 2021.

  • ARK Investment Management reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • ARK Investment Management sold 113,450 Ayala Pharmaceuticals, Inc. Common Stock shares in Q1 2021, an estimated $1.25M.
  • ARK Investment Management first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • ARK Investment Management's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $1.25M in Q4 2020.
  • 11 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q1 2021.

Based on ARK Investment Management's 13F filing for Q1 2021, filed 13 May 2021.